What is driving the latest competitive shifts in Health Tech?

Three forces are converging: retailer retrenchment from brick-and-mortar clinics, payer expansion of tech-enabled care pathways, and enterprise AI embedding inside EHRs and cloud stacks. Moves by Walmart and CVS Health recalibrate omnichannel care, while UnitedHealth Group and Optum leverage scale to extend navigation and home care. At the same time, Microsoft, Google Cloud, and Oracle Health are pushing AI and compliance infrastructure into core workflows, making it harder for point solutions to compete on features alone.

How are GLP‑1 telehealth providers like Hims & Hers and Ro adjusting their strategies?

They are pivoting toward supply assurance and enterprise integrations. Hims & Hers is prioritizing long-term compounding and supply agreements to stabilize fulfillment and pricing. Ro is expanding into diagnostics, labs, and ongoing monitoring to capture adherence and outcomes, making their offerings more attractive to employers and payers. These moves aim to secure volume, reduce churn, and support outcomes-linked contracts as reimbursement pressures intensify and compliance requirements grow.

Where is AI gaining the most traction in healthcare workflows right now?

AI is moving upstream into EHRs and cloud-native healthcare platforms, especially in clinical documentation, ambient scribing, imaging, and revenue-cycle automation. Microsoft’s Azure Health Data Services and Epic’s embedded assistants are reducing clinician burden while improving auditability. Google Cloud’s governance-focused tooling appeals to compliance-conscious CIOs. Oracle Health’s claims and denial management updates target payer-provider friction, positioning AI as a lever for both productivity and financial performance.

What regulatory updates are influencing product roadmaps and buyer decisions?

CMS’s CY2026 Physician Fee Schedule keeps telehealth flexibility and clarifies remote monitoring, encouraging enterprise investment in integrated platforms. The FDA’s ongoing guidance for AI/ML devices strengthens the case for Predetermined Change Control Plans and post‑market surveillance. In Europe, draft AI Act implementation guidance tightens expectations for high‑risk systems, particularly diagnostic support. Together, these actions push vendors to prioritize robust governance, data quality, and evidence pipelines to win contracts and maintain approvals.

What should startups focus on to remain competitive over the next year?

Startups should secure GLP‑1 supply chains if relevant, build outcomes-linked pricing, and integrate with payer and EHR data pipes. Differentiation will hinge on provable clinical and financial outcomes, audit-ready governance, and partnerships with cloud and EHR incumbents. Ambient scribing or niche RCM players should consider consolidation or joint go-to-market with Epic, Microsoft, or Google Cloud. Expect CIOs to favor fewer vendors with end-to-end capabilities and strong compliance postures under tightening budgets.

Retailers Retreat, Insurers Double Down and AI Moves Upstream in Health Tech

Over the past six weeks, Health Tech’s balance of power has tilted toward enterprise platforms and payers as retailers recalibrate their clinic strategies, GLP‑1 telehealth leaders chase supply-chain control, and new FDA/CMS actions reorder product roadmaps. The shake‑up is accelerating AI deployments inside EHRs and revenue-cycle stacks, pressuring point solutions to consolidate or pivot.

Published: December 1, 2025 By David Kim Category: Health Tech

Retailers Retreat, Insurers Double Down and AI Moves Upstream in Health Tech

Retail Clinics Pull Back as Payers Scale Tech-Enabled Care

A fresh round of strategic pivots among retail providers is reshaping the frontline of tech-enabled care. On November 19, 2025, Walmart outlined a tighter focus on digital care delivery and partnerships after winding down underperforming in-person sites earlier this year, intensifying competition with virtual-first incumbents like Teladoc Health and Amwell. The recalibration opens room for payers—most notably UnitedHealth Group via Optum—to scale tech-led navigation and home-based services.

Retail pharmacy giants are also revisiting omnichannel strategies. For more on related health tech developments. CVS Health highlighted tighter integration between specialty pharmacy and digital care journeys in November earnings materials, seeking margin insulation against reimbursement headwinds and GLP‑1 volatility, according to recent coverage by Reuters. Amazon Clinic continues expanding asynchronous modalities, leveraging Prime and pharmacy fulfillment advantages; Amazon’s healthcare posture is increasingly nibbling at traditional telehealth bundles, as noted in industry analysis.

GLP‑1 Telehealth Leaders Shift to Supply Assurance and Enterprise Pipes

GLP‑1 demand is forcing a rewrite of competitive moats. Hims & Hers Health said in mid-November that it is prioritizing long-term supply agreements and compounding capacity to stabilize fulfillment and pricing, while Ro is pushing deeper into care navigation, labs, and monitoring to capture lifetime value beyond the initial prescription. The move up the stack—into enterprise pipes, payer partnerships, and outcomes guarantees—threatens smaller direct-to-consumer platforms that lack formulary leverage.

Analysts say telehealth players with integrated diagnostics and specialty pharmacy support will win contracts as employers and payers seek cost control and adherence data, a dynamic underscored in recent analyst notes and corroborated by Gartner healthcare provider insights. For more on related Health Tech developments.

AI and EHRs: Enterprise Platforms Outpace Point Solutions

...

Read the full article at AI BUSINESS 2.0 NEWS